title: Survival with chronic myelogenous leukemia: the outcome of a patient who had one of the longest survivals.
authors.forename: A
authors.initials: A
authors.lastname: Ozet
authors.forename: G
authors.initials: G
authors.lastname: Ozet
authors.forename: Z
authors.initials: Z
authors.lastname: Calişkaner
authors.forename: S
authors.initials: S
authors.lastname: Kömürcü
authors.forename: F
authors.initials: F
authors.lastname: Arpact
authors.forename: O
authors.initials: O
authors.lastname: Berk
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D008297:Male; D017741:Survivors; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D006918:Hydroxyurea